Co-Authors
This is a "connection" page, showing publications co-authored by Paul Moss and Madhumita Shrotri.
Connection Strength
0.538
-
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study. Lancet Healthy Longev. 2021 Sep; 2(9):e544-e553.
Score: 0.241
-
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study. Lancet Infect Dis. 2021 11; 21(11):1529-1538.
Score: 0.238
-
Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study. Lancet Healthy Longev. 2021 Jun; 2(6):e362-e370.
Score: 0.059